Dr Agarwals Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dr Agarwals and similar public comparables like OdontoPrev, Agilon Health, Siloam Hospitals, MLP Sağlık and more.

Dr Agarwals Overview

About Dr Agarwals

Dr Agarwal’s Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.


Founded

2010

HQ

India

Employees

3.4K

Financials (LTM)

Revenue: $236M
EBITDA: $65M

EV

$1.8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dr Agarwals Financials

Dr Agarwals reported last 12-month revenue of $236M and EBITDA of $65M.

In the same LTM period, Dr Agarwals generated $185M in gross profit, $65M in EBITDA, and $17M in net income.

Revenue (LTM)


Dr Agarwals P&L

In the most recent fiscal year, Dr Agarwals reported revenue of $218M and EBITDA of $64M.

Dr Agarwals is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 30%, and net margin of 6%.

See analyst estimates for Dr Agarwals
LTMLast FY202320242025202620272028
Revenue$236M$218M$131M$168M$208M
Gross Profit$185M$139M$59M$76M$124M
Gross Margin78%64%45%45%60%
EBITDA$65M$64M$39M$50M$61M
EBITDA Margin27%30%30%30%30%
EBIT Margin15%14%15%15%14%
Net Profit$17M$14M$9M$9M$13M
Net Margin7%6%7%5%6%
Net Debt-$16M---

Financial data powered by Morningstar, Inc.

Dr Agarwals Stock Performance

Dr Agarwals has current market cap of $1.7B, and enterprise value of $1.8B.

Market Cap Evolution


Dr Agarwals' stock price is $5.25.

Dr Agarwals share price increased by 5.2% in the last 30 days, and by 6.9% in the last year.

Dr Agarwals has an EPS (earnings per share) of $0.04.

See more trading valuation data for Dr Agarwals
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.8B$1.7B-1.0%5.2%3.4%6.9%$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dr Agarwals Valuation Multiples

Dr Agarwals trades at 7.4x EV/Revenue multiple, and 27.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Dr Agarwals

EV / Revenue (LTM)


Dr Agarwals Financial Valuation Multiples

As of August 18, 2026, Dr Agarwals has market cap of $1.7B and EV of $1.8B.

Dr Agarwals has a P/E ratio of 100.6x.

LTMLast FY202320242025202620272028
EV/Revenue7.4x8.1x13.4x10.4x8.5x
EV/EBITDA27.1x27.2x44.7x35.3x28.6x
EV/EBIT49.6x57.2x88.5x70.9x59.5x
EV/Gross Profit9.5x12.6x29.8x23.1x14.1x
P/E100.6x119.4x185.6x191.0x131.9x
EV/FCFn/mn/m161.4xn/mn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dr Agarwals Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dr Agarwals Margins & Growth Rates

Dr Agarwals grew revenue by 23% and EBITDA by 14% in the last fiscal year.

In the most recent fiscal year, Dr Agarwals reported gross margin of 64%, EBITDA margin of 30%, and net margin of 6%.

See estimated margins and future growth rates for Dr Agarwals

Dr Agarwals Margins

Last FY202420252026202720282029
Gross Margin64%45%60%75%
EBITDA Margin30%30%30%28%
EBIT Margin14%15%14%15%
Net Margin6%5%6%7%
FCF Margin2%4%3%4%

Dr Agarwals Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth23%29%23%23%
Gross Profit Growth51%29%64%55%
EBITDA Growth14%26%23%16%
EBIT Growth35%25%19%31%
Net Profit Growth43%(3%)45%46%
FCF Growth104%(44%)(7%)68%

Data powered by FactSet, Inc. and Morningstar, Inc.

Dr Agarwals Operational KPIs

Dr Agarwals' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Dr Agarwals' Rule of 40 is 51% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dr Agarwals' Rule of X is 85% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Dr Agarwals
LTMLast FY202320242025202620272028
Rule of 4050%51%---
Bessemer Rule of X84%85%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue--4%4%4%
G&A Expenses to Revenue--2%2%2%
Opex to Revenue-50%30%30%46%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dr Agarwals Competitors

Dr Agarwals competitors include OdontoPrev, Agilon Health, Siloam Hospitals, MLP Sağlık, Akdital, Ardent Health, Burjeel Holdings, National Medical Care, Surgery Partners and Almoosa Health.

Most Dr Agarwals public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
OdontoPrev3.4x3.3x10.7x3.7x
Agilon Health0.2x0.3x(4.0x)(24.0x)
Siloam Hospitals2.4x2.3x10.6x9.1x
MLP Sağlık1.8x1.4x5.8x5.0x
Akdital4.3x3.4x14.5x11.5x
Ardent Health0.5x0.5x7.0x6.7x
Burjeel Holdings1.8x1.7x8.8x8.8x
National Medical Care3.7x3.6x12.9x13.0x

This data is available for Pro users. Sign up to see all Dr Agarwals competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dr Agarwals

When was Dr Agarwals founded?Dr Agarwals was founded in 2010.
Where is Dr Agarwals headquartered?Dr Agarwals is headquartered in India.
How many employees does Dr Agarwals have?As of today, Dr Agarwals has over 3K employees.
Who is the CEO of Dr Agarwals?Dr Agarwals' CEO is Adil Agarwal.
Is Dr Agarwals publicly listed?Yes, Dr Agarwals is a public company listed on National Stock Exchange of India.
What is the stock symbol of Dr Agarwals?Dr Agarwals trades under AGARWALEYE ticker.
When did Dr Agarwals go public?Dr Agarwals went public in 2025.
Who are competitors of Dr Agarwals?Dr Agarwals main competitors include OdontoPrev, Agilon Health, Siloam Hospitals, MLP Sağlık, Akdital, Ardent Health, Burjeel Holdings, National Medical Care, Surgery Partners, Almoosa Health.
What is the current market cap of Dr Agarwals?Dr Agarwals' current market cap is $1.7B.
What is the current revenue of Dr Agarwals?Dr Agarwals' last 12 months revenue is $236M.
What is the current revenue growth of Dr Agarwals?Dr Agarwals revenue growth (NTM/LTM) is 22%.
What is the current EV/Revenue multiple of Dr Agarwals?Current revenue multiple of Dr Agarwals is 7.4x.
What is the current EBITDA of Dr Agarwals?Dr Agarwals' last 12 months EBITDA is $65M.
What is Dr Agarwals' EBITDA margin?Dr Agarwals' last 12 months EBITDA margin is 27%.
What is the current EV/EBITDA multiple of Dr Agarwals?Current EBITDA multiple of Dr Agarwals is 27.1x.
What is the current FCF of Dr Agarwals?Dr Agarwals' last 12 months FCF is ($5M).
What is Dr Agarwals' FCF margin?Dr Agarwals' last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of Dr Agarwals?Current FCF multiple of Dr Agarwals is (366.3x).
How many companies Dr Agarwals has acquired to date?Dr Agarwals hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Dr Agarwals has invested to date?Dr Agarwals hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Dr Agarwals

Lists including Dr Agarwals

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial